Birzeit Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Birzeit Pharmaceuticals has a total shareholder equity of $105.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $125.1M and $20.1M respectively. Birzeit Pharmaceuticals's EBIT is $7.2M making its interest coverage ratio 76.8. It has cash and short-term investments of $17.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | 76.8x |
Cash | US$17.19m |
Equity | US$105.02m |
Total liabilities | US$20.12m |
Total assets | US$125.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BPC's short term assets ($67.2M) exceed its short term liabilities ($8.2M).
Long Term Liabilities: BPC's short term assets ($67.2M) exceed its long term liabilities ($11.9M).
Debt to Equity History and Analysis
Debt Level: BPC is debt free.
Reducing Debt: BPC has no debt compared to 5 years ago when its debt to equity ratio was 3.7%.
Debt Coverage: BPC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BPC has no debt, therefore coverage of interest payments is not a concern.